{"id":226164,"date":"2026-09-01T14:51:51","date_gmt":"2026-09-01T09:21:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=226164"},"modified":"2026-09-01T14:51:51","modified_gmt":"2026-09-01T09:21:51","slug":"why-asston-pharmaceuticals-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/","title":{"rendered":"Asston Pharmaceuticals (APL) Share Price Falls 8.46% to Rs 114: What Today&#8217;s Decline Shows"},"content":{"rendered":"<p style=\"margin-top:0!important;\">Asston Pharmaceuticals Share Price fell to Rs 114 on 01 September 2026, down 8.46% for the day. The move reduced the company\u2019s market capitalisation to Rs 106.01 crore. The Micro Cap healthcare stock opened at Rs 126.1, touched an intraday high of Rs 126.1 and later declined to Rs 114, which was also the session low at the time of this update.<\/p>\n<p>The supplied data confirms a sharp single-session decline, but it does not establish any company-specific reason behind the move. What is available is still useful: turnover stood at Rs 1.31 crore, the stock finished near the bottom of its intraday range, and the broader fundamental picture shows moderate valuation multiples alongside strong reported return ratios.<\/p>\n<p>That is why Asston Pharmaceuticals Share Price is drawing attention today. When a small-cap pharma stock records a notable fall while still screening with relatively solid profitability metrics, investors usually look beyond the day\u2019s move and compare valuation, peer positioning and industry context. This article stays strictly with the verified numbers provided.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Asston_Pharmaceuticals_APL_Share_Price_Today_Price_Action_Analysis\" title=\"Asston Pharmaceuticals (APL) Share Price Today: Price Action Analysis\">Asston Pharmaceuticals (APL) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Asston_Pharmaceuticals_APL_Fundamental_Analysis\" title=\"Asston Pharmaceuticals (APL) Fundamental Analysis\">Asston Pharmaceuticals (APL) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Why_Investors_Are_Watching_This_Stock\" title=\"Why Investors Are Watching This Stock\">Why Investors Are Watching This Stock<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#About_Asston_Pharmaceuticals\" title=\"About Asston Pharmaceuticals\">About Asston Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Track_Asston_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Asston Pharmaceuticals Share Price on Univest\">Track Asston Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Why_is_Asston_Pharmaceuticals_Share_Price_falling_today\" title=\"Why is Asston Pharmaceuticals Share Price falling today?\">Why is Asston Pharmaceuticals Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#What_is_Asston_Pharmaceuticals_Share_Price_today\" title=\"What is Asston Pharmaceuticals Share Price today?\">What is Asston Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#How_much_did_the_stock_decline_today\" title=\"How much did the stock decline today?\">How much did the stock decline today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#What_are_the_key_valuation_metrics\" title=\"What are the key valuation metrics?\">What are the key valuation metrics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#How_does_the_company_compare_with_the_pharma_industry_benchmark\" title=\"How does the company compare with the pharma industry benchmark?\">How does the company compare with the pharma industry benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#Are_the_return_ratios_strong\" title=\"Are the return ratios strong?\">Are the return ratios strong?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-asston-pharmaceuticals-share-price-fall-today-2026\/#How_does_it_compare_with_major_listed_peers\" title=\"How does it compare with major listed peers?\">How does it compare with major listed peers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Asston_Pharmaceuticals_APL_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Asston Pharmaceuticals (APL) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 114<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 124.54<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 10.54 (-8.46%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 126.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 126.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 114<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.31 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 106.01 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>From an intraday perspective, the pattern was weak. The stock opened above the previous close, but the opening price of Rs 126.1 also became the day\u2019s high. From there, it moved lower through the session and ended at Rs 114, matching the intraday low. That kind of price structure usually indicates that sellers remained in control for most of the day.<\/p>\n<p>In absolute terms, the stock was down Rs 10.54 from the previous close of Rs 124.54. Turnover of Rs 1.31 crore suggests the move came with visible trading activity. Because the company is classified as a Micro Cap, day-to-day swings can look sharper than they might in larger, more liquid names. For that reason, Asston Pharmaceuticals Share Price is best viewed not only through one session\u2019s decline but also through its valuation and operating metrics.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Asston_Pharmaceuticals_APL_Fundamental_Analysis\"><\/span><strong>Asston Pharmaceuticals (APL) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 106.01 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">50.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">42.64%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.54<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The fundamental snapshot is notable for two reasons. First, the stock is not priced at an extreme multiple on the supplied numbers. At Rs 114, it trades at a P\/E of 27.44 and a P\/B of 2.77. EPS is Rs 4.54 and book value per share is Rs 44.97. Dividend yield is 0%, so the stock is not currently reflected as a cash-yield story in the data provided.<\/p>\n<p>Second, the profitability ratios are strong on the face of the reported figures. ROE stands at 50.56% and ROCE at 42.64%. Those are high readings for any listed company and are especially important here because they contrast with a day when the stock price fell sharply. Put simply, the available data shows a stock under pressure in the market, but not one that screens weak on return ratios.<\/p>\n<p>Technical reference points add one more layer. The latest RSI is 67.34, while the stock remains above both its 50-day moving average of 82.26 and 200-day moving average of 81.37. Those figures do not explain the day\u2019s move, but they do show that the current price is still above the two longer moving-average markers supplied.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.87x to 667.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.34x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">50.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.81%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">42.64%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 106.01 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 683.05 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,252.9 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Asston Pharmaceuticals operates in the Healthcare sector under Pharmaceuticals &amp; Drugs. The benchmark covers 201 companies in the same industry, which gives a useful basis for context. On valuation, the company\u2019s P\/E of 27.44 is below the industry median of 30.92 and below the average of 48.02. On P\/B, its 2.77 is slightly below the median of 2.88 and below the average of 4.34.<\/p>\n<p>The benchmark ranges also show how wide dispersion can be in pharma. Industry P\/E values run from 3.87 to 667.16 across 168 companies, while P\/B ranges from -11.1 to 27.39 across 199 companies. Against that backdrop, Asston\u2019s multiples sit closer to the middle than the upper end.<\/p>\n<p>The profitability comparison is more striking. ROE of 50.56% is well above the industry median of 11.81% and average of 11.21. ROCE of 42.64% is also far above the median of 13.65% and average of 13.76. The main area where the company looks smaller than the industry norm is size: its market capitalisation of Rs 106.01 crore is below the benchmark median of Rs 683.05 crore and far below the average of Rs 14,252.9 crore. In short, Asston Pharmaceuticals Share Price is tied to a company that looks small by size, moderate on valuation and strong on reported returns.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The supplied peer set underlines how small Asston is versus major pharmaceutical names. Its market capitalisation of Rs 106.01 crore is far below Sun Pharmaceutical Industries, Divi&#8217;s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, all of which have market values above Rs 1,14,000 crore in the dataset.<\/p>\n<p>On valuation, Asston\u2019s P\/E of 27.44 is below Sun Pharma\u2019s 38.8, Divi\u2019s 83.91, Torrent\u2019s 86.82 and Cipla\u2019s 33.94, while slightly above Zydus Lifesciences at 25.69. Its P\/B of 2.77 is also below Sun Pharma\u2019s 5.43, Divi\u2019s 13.89, Torrent\u2019s 21.1 and Cipla\u2019s 3.25, and below Zydus at 4.3.<\/p>\n<p>Profitability is where the contrast is strongest. Asston\u2019s ROE of 50.56% is above all five supplied peers, and its ROCE of 42.64% is also higher than each of them. That does not explain today\u2019s decline, but it does show why the stock remains interesting despite the fall: on the reported numbers, its returns stand out more than its valuation multiples do.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_This_Stock\"><\/span><strong>Why Investors Are Watching This Stock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Asston Pharmaceuticals Share Price declined 8.46% to Rs 114 from Rs 124.54.<\/li>\n<li>The stock opened at Rs 126.1, made that its day\u2019s high, and then fell to Rs 114.<\/li>\n<li>Turnover was Rs 1.31 crore, showing active trading.<\/li>\n<li>P\/E of 27.44 and P\/B of 2.77 sit below industry averages of 48.02 and 4.34.<\/li>\n<li>ROE of 50.56% and ROCE of 42.64% are well above industry medians.<\/li>\n<li>Current price remains above the 50 DMA of 82.26 and 200 DMA of 81.37.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Asston_Pharmaceuticals\"><\/span><strong>About Asston Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Asston Pharmaceuticals belongs to the Healthcare sector and operates in Pharmaceuticals &amp; Drugs. Based on the supplied context, it is a listed Micro Cap company with a market capitalisation of Rs 106.01 crore. In sector terms, that makes it much smaller than the large branded peers referenced above, even though some of its profitability ratios compare favourably on the available data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Asston_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Asston Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/apl\/asston-pharmaceuticals-ltd-share-price-today\">Asston Pharmaceuticals (APL) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>Investors tracking Asston Pharmaceuticals Share Price can use Univest to compare live price action with valuation ratios, moving averages, peer metrics and industry benchmarks in one place. That can help separate a one-day move from the company\u2019s wider market context.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Asston_Pharmaceuticals_Share_Price_falling_today\"><\/span><strong>Why is Asston Pharmaceuticals Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The stock fell 8.46% to Rs 114 from the previous close of Rs 124.54. The supplied data confirms the decline and weak intraday structure, but it does not provide any verified company-specific trigger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Asston_Pharmaceuticals_Share_Price_today\"><\/span><strong>What is Asston Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Asston Pharmaceuticals Share Price was Rs 114 at the time of this update. The session range was Rs 126.1 on the high side and Rs 114 on the low side.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_the_stock_decline_today\"><\/span><strong>How much did the stock decline today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;It was down Rs 10.54 in absolute terms, which equals a decline of 8.46% for the day. The previous close was Rs 124.54. The stock moved 8.46% lower during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_valuation_metrics\"><\/span><strong>What are the key valuation metrics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied figures show a P\/E ratio of 27.44, a P\/B ratio of 2.77, EPS of Rs 4.54, book value per share of Rs 44.97 and dividend yield of 0%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_the_company_compare_with_the_pharma_industry_benchmark\"><\/span><strong>How does the company compare with the pharma industry benchmark?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Its P\/E of 27.44 is below the industry median of 30.92 and average of 48.02. Its P\/B of 2.77 is also slightly below the industry median of 2.88 and below the average of 4.34.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_the_return_ratios_strong\"><\/span><strong>Are the return ratios strong?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;On the supplied data, yes. ROE is 50.56% and ROCE is 42.64%, both well above the industry medians of 11.81% and 13.65%. ROE stands at 50.56%. ROCE stands at 42.64%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_it_compare_with_major_listed_peers\"><\/span><strong>How does it compare with major listed peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;It is far smaller by market value than Sun Pharma, Divi\u2019s, Torrent, Zydus and Cipla. However, its reported ROE and ROCE are higher than each of those supplied peers. Comparable listed companies include Sun Pharmaceutical Industries, Divi&#39;s Laboratories, Torrent Pharmaceuticals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Asston Pharmaceuticals Share Price falls to Rs 114. marking a 8.46% fall today. Market cap stands at Rs 106.01 crore.<\/p>\n","protected":false},"author":29,"featured_media":226163,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-226164","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["226163"],"rank_math_title":["Asston Pharmaceuticals Share Price Falls 8.46%: Analysis"],"rank_math_description":["Asston Pharmaceuticals Share Price fell 8.46% to Rs 114. Read price action, valuation, peer comparison and sector analysis for the pharma stock."],"rank_math_focus_keyword":["Asston Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Asston_Pharmaceuticals_APL_Share_Price_Falls_846_to_Rs_114_What_Todays_Decline_Shows_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/226164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=226164"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/226164\/revisions"}],"predecessor-version":[{"id":226165,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/226164\/revisions\/226165"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/226163"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=226164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=226164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=226164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}